Search

Your search keyword '"Panitumumab -- Forecasts and trends"' showing total 11 results

Search Constraints

Start Over You searched for: Descriptor "Panitumumab -- Forecasts and trends" Remove constraint Descriptor: "Panitumumab -- Forecasts and trends" Journal plus company updates Remove constraint Journal: plus company updates
11 results on '"Panitumumab -- Forecasts and trends"'

Search Results

1. Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth

2. Global Cancer Monoclonal Antibodies Market Report 2023: Players Include Amgen, Bristol Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche and Genmab

3. Colorectal Cancer Drugs Global Market Report 2023

4. Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector

5. Cancer Monoclonal Antibodies Market Report 2022: Widespread Adoption of Cost-Efficient Biosimilar Monoclonal Antibodies Driving Growth

6. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others

7. Global $16.4B Colorectal Cancer Drugs Market Outlook, 2026 - Diagnosed Incident Cases Expected to Increase by 27.3%, to 672,400 Cases by 2037

8. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum

9. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021

10. Laryngeal Cancer Therapeutics Market to Grow by USD 635.07 Million during 2021-2025|Amgen Inc. and AstraZeneca Plc Emerge as Key Contributors to Growth |Technavio

11. Global Cancer Monoclonal Antibodies Markets, 2020-2025

Catalog

Books, media, physical & digital resources